13F filing recap · Q4 2023
What did ArrowMark Partners buy in Q4 2023?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ArrowMark account, including accounts that belong to no fund below.
Stock value
$9.06B
Positions
307
Estimated turnover
26.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
VNOMViper Energy, Inc.$104.78Mreported value+3.34M sharesESTCElastic N.v.$35.04Mreported value+310.9K sharesBABAAlibaba Group Holding Limited$17.18Mreported value+221.6K sharesNGNENeurogene Inc.$10.18Mreported value+525.5K sharesCLXClorox Co /de/$9.84Mreported value+69.0K sharesRELYRemitly Global, Inc.$8.40Mreported value+432.8K sharesDORMDorman Products, Inc.$7.57Mreported value+90.7K sharesTNGXTango Therapeutics, Inc.$7.01Mreported value+708.4K sharesPHRPhreesia, Inc.$6.97Mreported value+301.0K sharesCHEChemed Corporation$6.87Mreported value+11.7K sharesMMSMaximus, Inc.$6.80Mreported value+81.1K sharesVFCV. F. Corporation$6.07Mreported value+323.0K sharesLAWCs Disco, Inc.$4.94Mreported value+651.0K sharesLBTYALiberty Global Ltd.$3.22Mreported value+181.2K sharesCSTMConstellium SE$3.13Mreported value+156.9K sharesMTCHMatch Group, Inc.$2.84Mreported value+77.8K sharesVIGLVigil Neuroscience, Inc.$978.4Kreported value+289.5K sharesSHOPShopify Inc.$911.4Kreported value+11.7K sharesSRZNSurrozen, Inc.$523.7Kreported value+55.1K sharesCVXChevron Corp$253.6Kreported value+1.7K sharesVZVerizon Communications Inc$230.3Kreported value+6.1K sharesBATRKAtlanta Braves Holdings, Inc.$205.9Kreported value+5.2K sharesFHNFirst Horizon Corp$141.6Kreported value+10.0K sharesXLOXilio Therapeutics, Inc.$45.9Kreported value+83.4K sharesSRZNWSurrozen, Inc.$2.2Kreported value+108.3K shares